MULTICENTER PHASE-II STUDY OF LOW-DOSE INTRAVESICAL EPIRUBICIN IN THE TREATMENT OF SUPERFICIAL BLADDER-CANCER

被引：6
|
作者：
WHELAN, P
CUMMING, JA
GARVIE, WHH
HARGREAVE, TB
KIRK, D
NEWLING, DWW
ROBINSON, MRG
SMITH, PH
机构：
[1] Department of Urology, St James's University Hospital, Leeds
来源：
BRITISH JOURNAL OF UROLOGY | 1991年 / 67卷 / 06期
关键词：
D O I：
10.1111/j.1464-410X.1991.tb15223.x
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Forty patients with multiple recurrent superficial bladder tumours received an 8-week course of weekly instillations of 4' epirubicin 30 mg in 50 ml saline. The overall response rate was 58% and side effects were minimal.
引用
收藏
页码：600 / 602
页数：3
相关论文
共 50 条
  • [31] ARE SIDE-EFFECTS OF TOPICAL BCG THERAPY FOR SUPERFICIAL BLADDER-CANCER MILDER WITH A LOW-DOSE
    MACK, D
    FRICK, J
    [J]. UROLOGE-AUSGABE A, 1992, 31 (02): : 88 - 90
  • [32] A LOW-DOSE BACILLUS CALMETTE-GUERIN REGIMEN IN SUPERFICIAL BLADDER-CANCER THERAPY - IS IT EFFECTIVE
    PAGANO, F
    BASSI, P
    MILANI, C
    MENEGHINI, A
    MARUZZI, D
    GARBEGLIO, A
    [J]. JOURNAL OF UROLOGY, 1991, 146 (01): : 32 - 35
  • [33] METASTATIC RENAL-CELL CANCER TREATED WITH LOW-DOSE INTERLEUKIN-2 - A PHASE-II MULTICENTER STUDY
    STOTER, G
    FOSSA, SD
    RUGARLI, C
    SYMANN, M
    JASMIN, C
    ISRAEL, L
    BIJMAN, JT
    PALMER, P
    FRANKS, CR
    PHILIP, T
    [J]. CANCER TREATMENT REVIEWS, 1989, 16 : 111 - 113
  • [34] BLADDER-CANCER IN PATIENTS ON LOW-DOSE METHOTREXATE AND CORTICOSTEROIDS
    MILLARD, RJ
    MCCREDIE, S
    [J]. LANCET, 1994, 343 (8907): : 1222 - 1223
  • [35] PHASE-I PHASE-II TRIAL OF INTRAVESICAL METHOTREXATE FOR SUPERFICIAL BLADDER-TUMORS
    STERNBERG, CN
    YAGODA, A
    BANDER, NH
    WHITMORE, WF
    HUFFMAN, JL
    FLEISHER, M
    MELAMED, M
    FANUCCHI, MP
    HOLLANDER, P
    VAUGHAN, ED
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 (03) : 265 - 269
  • [36] BLADDER WALL CALCIFICATION AFTER INTRAVESICAL MITOMYCIN-C TREATMENT OF SUPERFICIAL BLADDER-CANCER
    DRAGO, PC
    BADALAMENT, RA
    LUCAS, J
    DRAGO, JR
    [J]. JOURNAL OF UROLOGY, 1989, 142 (04): : 1071 - 1072
  • [37] LOW-DOSE INTRAVESICAL HEPARIN AS PROPHYLAXIS AGAINST RECURRENT NONINVASIVE (STAGE-TA) BLADDER-CANCER
    BITSCH, M
    HERMANN, GG
    ANDERSEN, JP
    STEVEN, K
    [J]. JOURNAL OF UROLOGY, 1990, 144 (03): : 635 - 636
  • [38] INTRAVESICAL BCG THERAPY OF SUPERFICIAL BLADDER-CANCER - STUDY OF ADVERSE-EFFECTS
    GALVAN, L
    AYANI, I
    ARRIZABALAGA, MJ
    RODRIGUEZSASIAIN, JM
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1994, 19 (02) : 101 - 104
  • [39] INTRAVESICAL SINGLE AND COMBINATION THERAPY IN SUPERFICIAL BLADDER-CANCER - AN EXPERIMENTAL-STUDY
    RUBBEN, H
    DAHM, HH
    VONUELFT, W
    RUTTGERS, L
    FRIEDRICHS, R
    LUTZEYER, W
    [J]. EUROPEAN UROLOGY, 1982, 8 (05) : 284 - 290
  • [40] INTRAVESICAL THIOTEPA PROPHYLAXIS OF SUPERFICIAL BLADDER-CANCER - A FOLLOW-UP-STUDY
    FOSSA, SD
    MILLER, A
    STENWIG, AE
    [J]. EUROPEAN UROLOGY, 1983, 9 (04) : 207 - 210
12345